NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Ceretas

Ceretas

Private
BrisbaneHealthcare & Life Scienceshttps://ceretas.com.au/

Last Round

Grant

Sep 22, 2025

Total Funding Raised

$3.4M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Ceretas is a healthtech company developing a non-invasive, safe, and portable therapeutic ultrasound platform to treat diseases of the brain, such as Alzheimer's disease.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Government Contracts

AI Layer

Non-AI

Keywords

focused ultrasoundneuromodulationblood-brain barrier openingAlzheimer's treatmentFUStherapeutic medical deviceBBB openingneurodegenerative diseasetargeted drug deliverymedtechportable ultrasound devicenon-invasive treatmentbrain stimulationuniversity spin-outclinical trialsMedical Research Future FundMRFF

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ceretas Comparables

Compare Ceretas with similar companies based on industry and business-model similarity.

Ceretas comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Grey Matter Neurosciences
88%
Delsona Therapeutics
82%
Cordance Medical
81%

Ceretas Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 22, 2025
SeedFeb 21, 2025

Ceretas Investors

Notable investors and investment history

Ceretas investors
InvestorRounds
Sequoia Asset ManagementSeed
CUREatorGrant
Caravel SecuritiesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 22, 2025

    $2.4M grant round from CUREator and MRFF.

  • Feb 21, 2025

    $1M round led by Ryan Laws and Sam Wetzler.

Ceretas Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ceretas Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ceretas's valuation, stock price, and market status.

Firmographic Details

HeadquartersBrisbane
Year Founded2024
Last FundingSep 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.